NCT01895322View on ClinicalTrials.gov

Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

August 31, 2014

Conditions
Chronic Renal Failure
Interventions
DRUG

OPC-41061

Trial Locations (6)

Unknown

Chubu Region

Hokkaido Region

Kanto Region

Kyushu Region

Shikoku Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY